SCHEMBL16774302

SCHEMBL16774302

CC(=O)N1c2ccc(-c3ccccc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C

nearest known ligand 0.86

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 20/20 0.86
▸ BRD2 P25440 20/20 0.86
▸ BRD3 Q15059 20/20 0.86
▸ CYP3A4 P08684 2/20 0.85
▸ CYP2C9 P11712 2/20 0.85
▸ CYP2C19 P33261 2/20 0.85
▸ TRIM24 O15164 1/20 0.85
▸ TAF1 P21675 1/20 0.85
▸ EP300 Q09472 1/20 0.85
▸ BRDT Q58F21 1/20 0.85
▸ PBRM1 Q86U86 1/20 0.85
▸ TAF1L Q8IZX4 1/20 0.85
▸ CREBBP Q92793 1/20 0.85
▸ BRWD1 Q9NSI6 1/20 0.85
▸ TRIM33 Q9UPN9 1/20 0.85
▸ CYP2D6 P10635 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26487028 0.92 BRD4 (1.00) BRD4BRD2BRD3CYP3A4CYP2C9
SCHEMBL26487039 0.92 BRD4 (1.00) BRD4BRD2BRD3CYP3A4CYP2C9
SCHEMBL26487036 0.92 BRD4 (1.00) BRD4BRD2BRD3CYP3A4CYP2C9
SCHEMBL26487023 0.92 BRD4 (1.00) BRD4BRD2BRD3CYP3A4CYP2C9
SCHEMBL11978838 0.92 BRD4 (1.00) BRD4BRD2BRD3CYP3A4CYP2C9
SCHEMBL1907498 0.92 BRD4 (1.00) BRD4BRD2BRD3CYP3A4CYP2C9
SCHEMBL1906368 0.92 BRD4 (1.00) BRD4BRD2BRD3CYP3A4CYP2C9
SCHEMBL22704705 0.92 BRD4 (1.00) BRD4BRD2BRD3CYP3A4CYP2C9
SCHEMBL11978889 0.92 BRD4 (1.00) BRD4BRD2BRD3CYP3A4CYP2C9
SCHEMBL29520173 0.92 BRD4 (1.00) BRD4BRD2BRD3CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023242597-A1 BIFUNCTIONAL MOLECULES FOR TARGETED PROTEIN DEGRADATION AMPHISTA THERAPEUTICS LIMITED (GB) 2023-12-21 — — WO disclosed
WO-2022129925-A1 NOVEL BIFUNCTIONAL MOLECULES FOR TARGETED PROTEIN DEGRADATION AMPHISTA THERAPEUTICS LIMITED (GB) 2022-06-23 — — WO disclosed
WO-2015081284-A1 BIVALENT BROMODOMAIN LIGANDS, AND METHODS OF USING SAME COFERON, INC. (US) 2015-06-04 — — WO disclosed
Send feedback